Speaker's Highlight

• Don Sin University of British Columbia, St. Paul Hospital (Canada)
  Kenneth R. Chapman Toronto General Hospital Research Institute (Canada)
• Parameswaran Nair McMaster University (Canada)
  Carolyn Calfee UCSF (U.S.A.)
• Gregory P. Downey University of Colorado School of Medicine (U.S.A.)
  David A. Schwartz University of Colorado School of Medicine (U.S.A.)
• Neil Schluger Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
  Nick Kim Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
• Nicola Hananiah Baylor College of Medicine (U.S.A.)
  Jae-Joon Yim Seoul National University College of Medicine (Republic of Korea)
• Koichiro Asano Tokai University School of Medicine (Japan)
  Diahn-Warng Perng Taipei Veterans General Hospital (Taiwan)
• Konstantinos Kostikas University of Ioannina (Greece)
  Karin Klooster University Medical Center Groningen (Kingdom of the Netherlands)

• Oxygen Therapy in Interstitial Lung Disease: Practical Considerations

  Interstitial lung disease (ILD) describes a broad group of conditions that cause inflammation, scarring, or both within the lungs. As fibrosis progresses, oxygen may move less efficiently from the air sacs into the bloodstream. Some people maintain acceptable oxygen levels at rest but become significantly hypoxaemic while walking, sleeping, or travelling at altitude.

  Oxygen therapy does not reverse pulmonary fibrosis or replace disease-specific treatment. It can, however, reduce the effects of low blood oxygen, support safer activity, improve exercise tolerance, and ease strain on the heart. In Australia, an effective plan also needs to account for equipment availability, long travel distances, household safety, and access to respiratory services outside major cities.

  What Oxygen Can and Cannot Do

  The decision to prescribe supplemental oxygen should be based on documented hypoxaemia rather than breathlessness alone. A person may feel very short of breath with a normal oxygen saturation because of reduced lung volume, anxiety, pulmonary hypertension, muscle deconditioning, or rapid breathing. Oxygen is unlikely to help these causes unless testing confirms low blood oxygen.

  Long-term oxygen therapy is commonly considered when resting oxygen saturation is persistently around 88% or lower, although thresholds and clinical interpretation vary. An arterial blood gas may be useful when readings are uncertain or carbon dioxide retention is a concern. Evidence for survival benefit is strongest in selected patients with severe chronic hypoxaemia, while benefits in ILD often focus on function, comfort, and quality of life.

  Oxygen should be prescribed with a purpose and a flow rate for each situation. The plan may specify separate settings for rest, walking, sleep, and air travel. A respiratory physician or experienced respiratory nurse can also review whether antifibrotic therapy, pulmonary rehabilitation, vaccination, or treatment for pulmonary hypertension should be addressed alongside oxygen.

  Assessing Need During Everyday Activity

  A clinic reading is only one part of the assessment. Pulse oximetry at rest can appear satisfactory while oxygen levels fall sharply during a six-minute walk test, climbing stairs, showering, or carrying groceries. Exercise testing helps identify exertional desaturation and shows how much oxygen is needed to maintain a safer target during movement.

  Overnight oximetry or a sleep study may identify nocturnal hypoxaemia, sleep apnoea, or hypoventilation. These problems require different treatment pathways, and oxygen should not be used as a substitute for continuous positive airway pressure when obstructive sleep apnoea is the primary issue. Cold hands, poor circulation, movement, nail products, and an inaccurate device can affect home readings.

  Many clinicians aim for a saturation of at least 92% during routine activity, but an individual target should be documented. People with coexisting chronic obstructive pulmonary disease or a history of carbon dioxide retention may need a different range. A written prescription should include the target saturation, flow setting, duration of use, and instructions for responding to worsening breathlessness.

  Selecting Equipment That Fits the Patient

  A stationary oxygen concentrator can provide oxygen continuously at home and is often suitable for people who need oxygen for many hours each day. It requires a reliable power supply and may be noisy in a bedroom. A portable concentrator or oxygen cylinder can support shopping, appointments, and pulmonary rehabilitation, but portable devices differ in battery life, weight, and whether they deliver continuous flow or pulse-dose oxygen.

  Pulse-dose equipment may not meet the needs of someone who breathes rapidly or requires oxygen during sleep. Patients should be tested with the actual device while walking, rather than assuming that a particular setting equals a prescribed continuous flow. People with advanced ILD may need high-flow oxygen during exertion, which can limit the usefulness of small portable concentrators.

  The Australian home oxygen market includes equipment supplied through state and territory programs, private providers, Department of Veterans’ Affairs arrangements, and other funding pathways. Eligibility and delivery processes vary. Someone living in Sydney or Melbourne may have several supplier options, while a patient in regional Western Australia, Queensland, or the Northern Territory may need additional planning for servicing, spare batteries, and cylinder delivery.

  Safety, Travel, and Daily Routines

  Oxygen supports combustion, so smoking, vaping, candles, gas cooking flames, fireplaces, and barbecues must be kept well away from the equipment. Oxygen should never be used near petroleum-based creams or aerosol sprays unless a pharmacist or clinician confirms that the product is safe. Tubing should be positioned to reduce trip hazards, particularly in hallways and bathrooms, and electrical leads should be checked regularly.

  Travel requires advance coordination. Long drives between Australian cities can create supply and battery challenges, especially in remote areas where replacement cylinders or technical support may not be readily available. Before travelling, confirm the oxygen supplier’s coverage, arrange sufficient consumables, carry a backup plan, and avoid leaving a concentrator in a hot vehicle.

  Air travel may be possible for stable patients, but cabin pressure can worsen hypoxaemia. The airline may require medical clearance and an approved portable oxygen concentrator; personal cylinders are generally subject to strict airline rules. A respiratory team can assess flight risk, sometimes with a hypoxic challenge test, and provide a travel prescription well before departure.

  Practical Recommendations For Australian Care Plans

  A useful oxygen plan should be reviewed as ILD changes. Pulmonary rehabilitation in centres such as those in Brisbane, Adelaide, Perth, or Canberra can show whether oxygen improves walking capacity and confidence. Occupational therapists may also help organise the home, conserve energy, and identify safer ways to bathe, cook, and manage stairs.

  The equipment should be judged by real-life performance rather than appearance or convenience. A lightweight device that cannot maintain the required saturation during walking is not an adequate solution. Funding rules, supplier response times, and access to replacement equipment should be discussed before the prescription is finalised.

  • Record oxygen requirements separately for rest, exertion, sleep, and air travel.
  • Complete a supervised walk test using the proposed portable device and flow setting.
  • Keep a written safety plan covering smoking, fire risks, tubing, power failure, and equipment breakdown.
  • Confirm funding, servicing, battery duration, and cylinder delivery before travelling outside the local area.
  • Arrange review after a significant infection, hospital admission, change in exercise tolerance, or sustained change in home saturation readings.

  The next practical step is to book a respiratory review for a six-minute walk test with documented oxygen titration and take the results to the equipment supplier before choosing a portable system.

  Richard Russell Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
• Mona Bafadhel King’s College London (United Kingdom)
  David Jackson Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
• James Chalmers University of Dundee (United Kingdom)
  David Price University of Aberdeen (United Kingdom)